Characterization of the hydroxycarboxylic acid receptor 2 in cats

Domestic Animal Endocrinology

Volumn 53, Issue , 2015, Pages 88-94

  Graff, E C ^a   Norris, O C ^a   Sandey, M ^a   Kemppainen, R J ^a   Judd, R L ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Adipocyte; Lipolysis; Obesity; Hydroxybutyrate

Indexed keywords

FELIDAE; MURINAE; RODENTIA;

G PROTEIN COUPLED RECEPTOR; NICOTINIC RECEPTOR;

ADIPOCYTE; ANIMAL; CAT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ADIPOCYTES; ANIMALS; CATS; FEMALE; GENE EXPRESSION REGULATION; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC;

EID: 84936804050     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2015.06.001     Document Type: Article

References (55)

1. Blad C.C., Ahmed K., Ijerman A.P., Offermanns S. Biological and pharmacological roles of HCA receptors. Adv Pharmacol 2011, 62:219-250.
2. Taggart A.K., Kero J., Gan X., Cai T.Q., Cheng K., Ippolito M., Ren N., Kaplan R., Wu K., Wu T.J., Jin L., Liaw C., Chen R., Richman J., Connolly D., Offermanns S., Wright S.D., Waters M.G. (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 2005, 280:26649-26652.
3. Offermanns S., Colletti S.L., Lovenberg T.W., Semple G., Wise A., Ijerman A.P. International Union of Basic and Clinical Pharmacology. LXXXII: nomenclature and classification of hydroxy-carboxylic acid receptors (GPR81, GPR109A, and GPR109B). Pharmacol Rev 2011, 63:269-290.
4. Tunaru S., Kero J., Schaub A., Wufka C., Blaukat A., Pfeffer K., Offermanns S. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 2003, 9:352-355.
5. Hanson J., Gille A., Zwykiel S., Lukasova M., Clausen B.E., Ahmed K., Tunaru S., Wirth A., Offermanns S. Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice. J Clin Invest 2010, 120:2910-2919.
6. Maciejewski-Lenoir D., Richman J.G., Hakak Y., Gaidarov I., Behan D.P., Connolly D.T. Langerhans cells release prostaglandin D2 in response to nicotinic acid. J Invest Dermatol 2006, 126:2637-2646.
7. Tang H., Lu J.Y., Zheng X., Yang Y., Reagan J.D. The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist. Biochem Biophys Res Commun 2008, 375:562-565.
8. Soga T., Kamohara M., Takasaki J., Matsumoto S., Saito T., Ohishi T., Hiyama H., Matsuo A., Matsushime H., Furuichi K. Molecular identification of nicotinic acid receptor. Biochem Biophys Res Commun 2003, 303:364-369.
9. Wise A., Foord S.M., Fraser N.J., Barnes A.A., Elshourbagy N., Eilert M., Ignar D.M., Murdock P.R., Steplewski K., Green A., Brown A.J., Dowell S.J., Szekeres P.G., Hassall D.G., Marshall F.H., Wilson S., Pike N.B. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 2003, 278:9869-9874.
10. Schaub A., Futterer A., Pfeffer K. PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily. Eur J Immunol 2001, 31:3714-3725.
11. Elangovan S., Pathania R., Ramachandran S., Ananth S., Padia R.N., Lan L., Singh N., Martin P.M., Hawthorn L., Prasad P.D., Ganapathy V., Thangaraju M. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. Cancer Res 2014, 74:1166-1178.
12. Gambhir D., Ananth S., Veeranan-Karmegam R., Elangovan S., Hester S., Jennings E., Offermanns S., Nussbaum J.J., Smith S.B., Thangaraju M., Ganapathy V., Martin P.M. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy. Invest Ophthalmol Vis Sci 2012, 53:2208-2217.
13. Rahman M., Muhammad S., Khan M.A., Chen H., Ridder D.A., Müller-Fielitz H., Pokorná B., Vollbrandt T., Stölting I., Nadrowitz R., Okun J.G., Offermanns S., Schwaninger M. The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat Commun 2014, 5:3944.
14. Kostylina G., Simon D., Fey M.F., Yousefi S., Simon H.U. Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A). Cell Death Differ 2008, 15:134-142.
15. Li X., Millar J.S., Brownell N., Briand F., Rader D.J. Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes. Biochem Pharmacol 2010, 80:1450-1457.
16. Ge H., Weiszmann J., Reagan J.D., Gupte J., Baribault H., Gyuris T., Chen J.-L., Tian H., Li Y. Elucidation of signaling and functional activities of an orphan GPCR, GPR81. J Lipid Res 2008, 49:797-803.
17. Titgemeyer E.C., Mamedova L.K., Spivey K.S., Farney J.K., Bradford B.J. An unusual distribution of the niacin receptor in cattle. J Dairy Sci 2011, 94:4962-4967.
18. Kenez A., Locher L., Rehage J., Danicke S., Huber K. Agonists of the G protein-coupled receptor 109A-mediated pathway promote antilipolysis by reducing serine residue 563 phosphorylation of hormone-sensitive lipase in bovine adipose tissue explants. J Dairy Sci 2014, 97:3626-3634.
19. Kopp C., Hosseini A., Singh S.P., Regenhard P., Khalilvandi-Behroozyar H., Sauerwein H., Mielenz M. Nicotinic acid increases adiponectin secretion from differentiated bovine preadipocytes through G-protein coupled receptor signaling. Int J Mol Sci 2014, 15:21401-21418.
20. Hoenig M. The cat as a model for human obesity and diabetes. J Diabetes Sci Technol 2012, 6:525-533.
21. Osto M., Zini E., Reusch C.E., Lutz T.A. Diabetes from humans to cats. Gen Comp Endocrinol 2013, 182:48-53.
22. Van de Velde H., Janssens G.P.J., de Rooster H., Polis I., Peters I., Ducatelle R., Nguyen P., Buyse J., Rochus K., Xu J., Verbrugghe A., Hesta M. The cat as a model for human obesity: insights into depot-specific inflammation associated with feline obesity. Br J Nutr 2013, 110:1326-1335.
23. Muranaka S., Mori N., Hatano Y., Saito T.R., Lee P., Kojima M., Kigure M., Yagishita M., Arai T. Obesity induced changes to plasma adiponectin concentration and cholesterol lipoprotein composition profile in cats. Res Vet Sci 2011, 91:358-361.
24. Hoenig M., Thomaseth K., Waldron M., Ferguson D.C. Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss. Am J Physiol Regul Integr Comp Physiol 2007, 292:R227-R234.
25. McCue M.D. Starvation physiology: reviewing the different strategies animals use to survive a common challenge. Comp Biochem Physiol Part A Mol Integr Physiol 2010, 156:1-18.
26. Weingart C., Lotz F., Kohn B. Measurement of β-hydroxybutyrate in cats with nonketotic diabetes mellitus, diabetic ketosis, and diabetic ketoacidosis. J Vet Diagn Invest 2012, 24:295-300.
27. Aroch I., Shechter-Polak M., Segev G. A retrospective study of serum beta-hydroxybutyric acid in 215 ill cats: clinical signs, laboratory findings and diagnoses. Vet J 2012, 191:240-245.
28. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45.
29. Carswell K.A., Lee M.J., Fried S.K. Culture of isolated human adipocytes and isolated adipose tissue. Methods Mol Biol 2012, 806:203-214.
30. Tunaru S., Lattig J., Kero J., Krause G., Offermanns S. Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G). Mol Pharmacol 2005, 68:1271-1280.
31. Nelson R.W., Reusch C.E. Animal models of disease: classification and etiology of diabetes in dogs and cats. J Endocrinol 2014, 222:T1-9.
32. Cave N.J., Allan F.J., Schokkenbroek S.L., Metekohy C.A., Pfeiffer D.U. A cross-sectional study to compare changes in the prevalence and risk factors for feline obesity between 1993 and 2007 in New Zealand. Prev Vet Med 2012, 107:121-133.
33. Colliard L., Paragon B.M., Lemuet B., Benet J.J., Blanchard G. Prevalence and risk factors of obesity in an urban population of healthy cats. J Feline Med Surg 2009, 11:135-140.
34. Courcier E.A., O'Higgins R., Mellor D.J., Yam P.S. Prevalence and risk factors for feline obesity in a first opinion practice in Glasgow, Scotland. J Feline Med Surg 2010, 12:746-753.
35. Lund E.M., Armstrong P., Kirk C.A., Klausner J. Prevalence and risk factors for obesity in adult cats from private US veterinary practices. Intern J Appl Res Vet Med 2005, 3:88-96.
36. Wanders D., Graff E.C., White B.D., Judd R.L. Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice. PLoS One 2013, 8:e71285.
37. Lukasova M., Malaval C., Gille A., Kero J., Offermanns S. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J Clin Invest 2011, 121:1163-1173.
38. Halberg N., Wernstedt-Asterholm I., Scherer P.E. The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am 2008, 37:753-768. x-xi.
39. Ohashi K., Parker J.L., Ouchi N., Higuchi A., Vita J.A., Gokce N., Pedersen A.A., Kalthoff C., Tullin S., Sams A., Summer R., Walsh K. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 2010, 285:6153-6160.
40. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.
41. Plaisance E.P., Lukasova M., Offermanns S., Zhang Y., Cao G., Judd R.L. Niacin stimulates adiponectin secretion through the GPR109A receptor. Am J Physiol Endocrinol Metab 2009, 296:E549-E558.
42. Fraterrigo G., Fabbrini E., Mittendorfer B., O'Rahilly S., Scherer P.E., Patterson B.W., Klein S. Relationship between changes in plasma adiponectin concentration and insulin sensitivity after niacin therapy. Cardiorenal Med 2012, 2:211-217.
43. Wanders D., Plaisance E.P., Judd R.L. Pharmacological effects of lipid-lowering drugs on circulating adipokines. World J Diabetes 2010, 1:116-128.
44. Digby J.E., Martinez F., Jefferson A., Ruparelia N., Chai J., Wamil M., Greaves D.R., Choudhury R.P. Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms. Arterioscler Thromb Vasc Biol 2012, 32:669-676.
45. Digby J.E., McNeill E., Dyar O.J., Lam V., Greaves D.R., Choudhury R.P. Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin. Atherosclerosis 2010, 209:89-95.
46. Lee J.M., Robson M.D., Yu L.M., Shirodaria C.C., Cunnington C., Kylintireas I., Digby J.E., Bannister T., Handa A., Wiesmann F., Durrington P.N., Channon K.M., Neubauer S., Choudhury R.P. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol 2009, 54:1787-1794.
47. Ruparelia N., Digby J.E., Choudhury R.P. Effects of niacin on atherosclerosis and vascular function. Curr Opin Cardiol 2011, 26:66-70.
48. Wanders D., Graff E.C., Judd R.L. Effects of high fat diet on GPR109A and GPR81 gene expression. Biochem Biophys Res Commun 2012, 425:278-283.
49. Zoran D.L. Obesity in dogs and cats: a metabolic and endocrine disorder. Vet Clin North Am Small Anim Pract 2010, 40:221-239.
50. Hoenig M., Pach N., Thomaseth K., Le A., Schaeffer D., Ferguson D.C. Cats differ from other species in their cytokine and antioxidant enzyme response when developing obesity. Obesity (Silver Spring) 2013, 21:E407-E414.
51. Lusby A.L., Kirk C.A., Bartges J.W. The role of key adipokines in obesity and insulin resistance in cats. J Am Vet Med Assoc 2009, 235:518-522.
52. Cnop M., Landchild M.J., Vidal J., Havel P.J., Knowles N.G., Carr D.R., Wang F., Hull R.L., Boyko E.J., Retzlaff B.M. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations distinct metabolic effects of two fat compartments. Diabetes 2002, 51:1005-1015.
53. Hoenig M., Thomaseth K., Brandao J., Waldron M., Ferguson D.C. Assessment and mathematical modeling of glucose turnover and insulin sensitivity in lean and obese cats. Domest Anim Endocrinol 2006, 31:373-389.
54. Rand J.S. Diabetic ketoacidosis and hyperosmolar hyperglycemic state in cats. Vet Clin North Am Small Anim Pract 2013, 43:367-379.
55. Armstrong P.J., Blanchard G. Hepatic lipidosis in cats. Vet Clin North Am Small Anim Pract 2009, 39:599-616.